RSI showing extremely oversold. Stop losses triggered on the way down.
Yes, the product missed FDA approval but the company still has strong financials: low debt and lots of cash at hand.
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在
使用条款阅读更多信息。
